US Patent Number

7521198

Publication Date

4-21-2009

Abstract

Methods for detecting atherosclerotic plaque and quantifying the amount of Group V sPLA2 in plasma are disclosed. These methods can be used to assess the risk of cardiovascular pathology in a patient.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

10/445,320

Filing Date

05/27/2003

Share

COinS